Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inmune Bio (INMB) Asset Utilization Ratio (2021 - 2025)

Inmune Bio (INMB) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.0 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 401.91% to 0.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0 through Dec 2025, up 401.91% year-over-year, with the annual reading at 0.0 for FY2025, 379.56% up from the prior year.
  • Asset Utilization Ratio hit 0.0 in Q4 2025 for Inmune Bio, up from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q3 2022 to a low of 0.0 in Q2 2021.
  • Historically, Asset Utilization Ratio has averaged 0.0 across 5 years, with a median of 0.0 in 2021.
  • Biggest five-year swings in Asset Utilization Ratio: surged 6084.1% in 2022 and later tumbled 88.29% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.0 in 2021, then surged by 159.06% to 0.0 in 2022, then plummeted by 42.67% to 0.0 in 2023, then tumbled by 88.29% to 0.0 in 2024, then surged by 401.91% to 0.0 in 2025.
  • Business Quant data shows Asset Utilization Ratio for INMB at 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q2 2025.